Loading clinical trials...
Loading clinical trials...
Text Messaging to Promote Mobility in Overweight/Obese Adults With Peripheral Artery Disease
By doing this study, researchers hope to learn about the feasibility of using a mobile application to help overweight or obese adults with PAD increase their walking distance and lose weight.
Peripheral artery disease (PAD) or poor leg circulation affects 8 to 12 million Americans including non-Hispanic Whites, African Americans and Latinos. Having PAD can limit how far you can walk. Many patients with PAD are also overweight or obese. Weight loss among overweight or obese adults with PAD may improve walking distance. Given how common obesity or being overweight is among persons with PAD, interventions are needed to address weight loss in this population.
Age
50 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Kansas School of Medicine
Wichita, Kansas, United States
Start Date
October 18, 2018
Primary Completion Date
June 5, 2019
Completion Date
June 5, 2019
Last Updated
May 26, 2023
29
ACTUAL participants
PACE
BEHAVIORAL
Diet
BEHAVIORAL
App
OTHER
Face-to-face
OTHER
Lead Sponsor
University of Kansas Medical Center
Collaborators
NCT06277232
NCT07395973
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05301413